Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical protocol for monitoring of targeted therapies in rheumatoid arthritis.

× No keyword cloud information.

6 in total

1. Cost-effectiveness treatment with Rituximab in patients with rheumatoid arthritis in real life.

Authors: Maurizio Benucci; Gianantonio Saviola; Paola Baiardi; Mariangela Manfredi
Journal: Rheumatol Int Date: 2010-05-16 Impact factor: 2.631

2. Response criteria for rheumatoid arthritis in clinical practice: how useful are they?

Authors: A Gülfe; P Geborek; T Saxne
Journal: Ann Rheum Dis Date: 2005-03-10 Impact factor: 19.103

3. Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.

Authors: P Geborek; M Crnkic; I F Petersson; T Saxne
Journal: Ann Rheum Dis Date: 2002-09 Impact factor: 19.103

4. EuroQol-5 dimensions utility gain according to British and Swedish preference sets in rheumatoid arthritis treated with abatacept, rituximab, tocilizumab, or tumour necrosis factor inhibitors: a prospective cohort study from southern Sweden.

Authors: Anders Gülfe; Johan K Wallman; Lars Erik Kristensen
Journal: Arthritis Res Ther Date: 2016-02-19 Impact factor: 5.156

5. Disease activity level, remission and response in established rheumatoid arthritis: performance of various criteria sets in an observational cohort, treated with anti-TNF agents.

Authors: Anders Gülfe; Daniel Aletaha; Tore Saxne; Pierre Geborek
Journal: BMC Musculoskelet Disord Date: 2009-04-23 Impact factor: 2.362

6. Rituximab in clinical practice: dosage, drug adherence, Ig levels, infections, and drug antibodies.

Authors: Jon Thorkell Einarsson; Max Evert; Pierre Geborek; Tore Saxne; Maria Lundgren; Meliha C Kapetanovic
Journal: Clin Rheumatol Date: 2017-10-04 Impact factor: 2.980

6 in total